Insmed Inc (NASDAQ: INSM) kicked off on Thursday, up 3.49% from the previous trading day, before settling in for the closing price of $70.20. Over the past 52 weeks, INSM has traded in a range of $21.92-$84.91.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 21.77% over the past five years. While this was happening, its average annual earnings per share was recorded 5.78%. With a float of $177.62 million, this company’s outstanding shares have now reached $179.38 million.
Let’s look at the performance matrix of the company that is accounted for 1271 employees. In terms of profitability, gross margin is 75.73%, operating margin of -219.95%, and the pretax margin is -250.22%.
Insmed Inc (INSM) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Insmed Inc is 2.31%, while institutional ownership is 106.38%. The most recent insider transaction that took place on Apr 15 ’25, was worth 479,177. In this transaction Chair and CEO of this company sold 6,830 shares at a rate of $70.16, taking the stock ownership to the 233,924 shares. Before that another transaction happened on Apr 15 ’25, when Company’s Officer proposed sale 6,830 for $70.12, making the entire transaction worth $478,933.
Insmed Inc (INSM) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.37 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 5.78% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 50.65% during the next five years compared to -13.12% drop over the previous five years of trading.
Insmed Inc (NASDAQ: INSM) Trading Performance Indicators
Take a look at Insmed Inc’s (INSM) current performance indicators. Last quarter, stock had a quick ratio of 5.12. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 36.32.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.59, a number that is poised to hit -1.34 in the next quarter and is forecasted to reach -3.73 in one year’s time.
Technical Analysis of Insmed Inc (INSM)
Insmed Inc (NASDAQ: INSM) saw its 5-day average volume 1.76 million, a negative change from its year-to-date volume of 1.98 million. As of the previous 9 days, the stock’s Stochastic %D was 85.85%. Additionally, its Average True Range was 3.75.
During the past 100 days, Insmed Inc’s (INSM) raw stochastic average was set at 49.98%, which indicates a significant decrease from 75.15% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 57.93% in the past 14 days, which was higher than the 38.73% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $76.03, while its 200-day Moving Average is $73.81. Nevertheless, the first resistance level for the watch stands at $73.59 in the near term. At $74.54, the stock is likely to face the second major resistance level. The third major resistance level sits at $76.40. If the price goes on to break the first support level at $70.78, it is likely to go to the next support level at $68.92. Assuming the price breaks the second support level, the third support level stands at $67.97.
Insmed Inc (NASDAQ: INSM) Key Stats
The company with the Market Capitalisation of 13.21 billion has total of 181,820K Shares Outstanding. Its annual sales at the moment are 363,710 K in contrast with the sum of -913,770 K annual income. Company’s last quarter sales were recorded 104,440 K and last quarter income was -235,550 K.
